MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Modern Pathology

• Publication date

  2016-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/modpathol.2016.38PMID 26916073PMCID PMC11793840
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.

  2015cited by this paper
• Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?

  2014cited by this paper
• Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes.

  2014cited by this paper
• Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up.

  2014cited by this paper
• miR-205 acts as a tumor radiosensitizer by targeting ZEB1 and Ubc13

  2014cited by this paper
• The role of microRNAs in human breast cancer progression

  2014cited by this paper
• The MicroRNA-23b/27b/24 Cluster Promotes Breast Cancer Lung Metastasis by Targeting Metastasis-suppressive Gene Prosaposin

  2014cited by this paper
• MicroRNAs as regulatory elements in triple negative breast cancer.

  2014cited by this paper
• Loss of the polycomb protein Mel-18 enhances the epithelial–mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer

  2014cited by this paper
• microRNAs in breast cancer development and treatment.

  2014cited by this paper
• microRNAs: a new class of breast cancer biomarkers

  2014cited by this paper
• miRNA expression profiling of inflammatory breast cancer identifies a 5‐miRNA signature predictive of breast tumor aggressiveness

  2013cited by this paper
• Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancer.

  2013cited by this paper
• Role of microRNAs in breast cancer

  2013cited by this paper
• Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets

  2013cited by this paper
• Genetic and epigenetic signatures of breast cancer subtypes.

  2012cited by this paper
• miRNAs in breast cancer: ready for real time?

  2012cited by this paper
• Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs

  2012cited by this paper
• RETRACTED ARTICLE: Roles of MicroRNAs and Other Non-coding RNAs in Breast Cancer Metastasis

  2012cited by this paper
• Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer.

  2012cited by this paper
• Non-Coding RNAs as Regulators of Mammary Development and Breast Cancer

  2012cited by this paper
• Oncosuppressive role of p53‐induced miR‐205 in triple negative breast cancer

  2012cited by this paper
• Biological and prognostic associations of miR‐205 and let‐7b in breast cancer revealed by in situ hybridization analysis of micro‐RNA expression in arrays of archival tumour tissue

  2012cited by this paper
• Expression analysis of MiR-21, MiR-205, and MiR-342 in breast cancer in Iran.

  2012cited by this paper
• MicroRNA-mediated breast cancer metastasis: from primary site to distant organs

  2012cited by this paper
• ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer.

  2012cited by this paper
• Involvement of NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial–mesenchymal transition of breast cancer cells

  2011cited by this paper
• MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer.

  2011cited by this paper
• Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer

  2011cited by this paper
• miRNAs in breast cancer tumorigenesis (Review)

  2011cited by this paper
• Implication of miRNA in the diagnosis and treatment of breast cancer

  2011cited by this paper
• MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer

  2011cited by this paper
• Intracellular and extracellular microRNAs in breast cancer.

  2011cited by this paper
• MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.

  2011cited by this paper
• MicroRNAs: toward the clinic for breast cancer patients.

  2011cited by this paper
• Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer

  2011cited by this paper
• Breast cancer and microRNAs: therapeutic impact.

  2011cited by this paper
• Emerging role of microRNAs in drug-resistant breast cancer.

  2011cited by this paper
• Inflammatory breast cancer: what progress have we made?

  2011cited by this paper
• MicroRNAs and their target gene networks in breast cancer

  2010cited by this paper
• Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis

  2010cited by this paper
• Deconstructing the molecular portraits of breast cancer

  2010cited by this paper
• miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death.

  2010cited by this paper
• A putative role for microRNA-205 in mammary epithelial cell progenitors

  2010cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

  2010cited by this paper
• MicroRNAs in breast cancer pathogenesis.

  2010cited by this paper
• American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

  2010cited by this paper
• MiRNAs as biomarkers and therapeutic targets in cancer.

  2010cited by this paper
• Signatures of microRNAs and selected microRNA target genes in human melanoma.

  2010cited by this paper
• MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancer

  2010cited by this paper
• Gene expression profiling of inflammatory breast cancer

  2010cited by this paper
• miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

  2010cited by this paper
• Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells

  2010cited by this paper
• Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype

  2010cited by this paper
• Micro‐RNAs and breast cancer

  2010cited by this paper
• miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.

  2009cited by this paper
• MicroRNA involvement in the pathogenesis and management of breast cancer

  2009cited by this paper
• Targeting miR-205 in breast cancer

  2009cited by this paper
• Expression profile of mammalian microRNAs in endometrioid adenocarcinoma

  2009cited by this paper
• microRNA-205 regulates HER3 in human breast cancer.

  2009cited by this paper
• MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

  2009cited by this paper
• Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

  2009cited by this paper
• Characterisation of microRNA expression in post-natal mouse mammary gland development

  2009cited by this paper
• Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types

  2009cited by this paper
• MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer

  2009cited by this paper
• Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.

  2008cited by this paper
• MicroRNA expression profiling using microarrays

  2008cited by this paper
• MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia

  2008cited by this paper
• Suppression of cell growth and invasion by miR-205 in breast cancer

  2008cited by this paper
• A stromal gene signature associated with inflammatory breast cancer

  2008cited by this paper
• MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

  2007cited by this paper
• Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.

  2007cited by this paper
• Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis

  2007cited by this paper
• Micro-RNA profiling in kidney and bladder cancers.

  2007cited by this paper
• Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling

  2006cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

  2006cited by this paper
• Molecular Heterogeneity of Inflammatory Breast Cancer: A Hyperproliferative Phenotype

  2006cited by this paper
• Epidemiology of Inflammatory Breast Cancer (IBC)

  2006cited by this paper
• Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant Chemotherapy

  2006cited by this paper
• Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.

  2005cited by this paper
• Distinct Molecular Signature of Inflammatory Breast Cancer by cDNA Microarray Analysis

  2005cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.

  2005cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• Molecular Profiling of Inflammatory Breast Cancer

  2004cited by this paper
• Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy

  2004cited by this paper
• An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues.

  2004cited by this paper
• MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms

  2003cited by this paper
• Persistent E-Cadherin Expression in Inflammatory Breast Cancer

  2001cited by this paper

• Advances in targeted therapy for inflammatory breast cancer: nanomaterials, conventional treatments, and clinical applications

  2025cites this paper
• Emerging mechanisms of triple-negative breast cancer radioresistance: Interplay between cancer cell mechanisms and the tumor immune microenvironment.

  2025cites this paper
• Reawakening the Master Switches in Triple-Negative Breast Cancer: A Strategic Blueprint for Confronting Metastasis and Chemoresistance via MicroRNA-200/205: a systematic review.

  2024cites this paper
• Assessment of serum microRNA-21 and miRNA-205 as diagnostic markers for stage I and II breast cancer in Indian population.

  2023cites this paper
• Bioinformatic miRNA-mRNAs Analysis Revels to miR-934 as a Potential Regulator of the Epithelial–Mesenchymal Transition in Triple-Negative Breast Cancer

  2023cites this paper
• The Emerging Role of microRNAs as Novel Diagnostic and Therapeutic Tools For Breast Cancer: a systematic review

  2023cites this paper
• Deregulated MicroRNAs involved in P53 Signaling Pathway in Breast Cancer with Focus on Triple-negative Breast Cancer.

  2023cites this paper
• LncRNA CYP4A22-AS1 promotes the progression of lung adenocarcinoma through the miR-205-5p/EREG and miR-34c-5p/BCL-2 axes

  2023cites this paper
• Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer

  2022cites this paper
• Dual function miR-205 is positively associated with ER and negatively with five-year survival in breast cancer patients.

  2022cites this paper
• Knockdown of lncRNA TapSAKI alleviates LPS-induced injury in HK-2 cells through the miR-205/IRF3 pathway

  2021cites this paper
• Highly sensitive analysis strategies of microRNAs based on electrochemiluminescence

  2021cites this paper
• MicroRNAs Involved in Inflammatory Breast Cancer: Oncogene and Tumor Suppressors with Possible Targets

  2021cites this paper
• Triple Negative Breast Cancer in the Era of miRNA.

  2020cites this paper
• Biological subtype, treatment response and outcomes in inflammatory breast cancer using data from the National Cancer Database

  2020cites this paper
• Genetic ablation of bone marrow beta-adrenergic receptors in mice modulates miRNA-transcriptome networks of neuroinflammation in the paraventricular nucleus.

  2020cites this paper
• Porphyromonas gingivalis Inhibition of MicroRNA-205-5p Expression Modulates Proinflammatory Cytokines in Gingival Epithelial Cells

  2020cites this paper
• Prognostic Role of microRNA-205 in Human Gynecological Cancer: A Meta-Analysis of Fourteen Studies

  2020cites this paper
• Automated Five-Color Multiplex Co-detection of MicroRNA and Protein Expression in Fixed Tissue Specimens.

  2020cites this paper
• miR-205/RunX2 axis negatively regulates CD44+/CD24- breast cancer stem cell activity.

  2020influential citation
• miR-205: A Potential Biomedicine for Cancer Therapy

  2020cites this paper
• Biomarkers for Inflammatory Breast Cancer: Diagnostic and Therapeutic Utility

  2020cites this paper
• Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value

  2020cites this paper
• miR-205 in Breast Cancer: State of the Art

  2020cites this paper
• BCTT_A_231502 153..163

  2020cites this paper
• miR-205 Suppresses Pulmonary Fibrosis By Targeting GATA3 Through Inhibition Of Endoplasmic Reticulum Stress.

  2019cites this paper
• Downregulation of miR-139-5p promotes prostate cancer progression through regulation of SOX5.

  2019cites this paper
• Expression signatures and roles of microRNAs in inflammatory breast cancer

  2019cites this paper
• miR‐205‐3p promotes proliferation and reduces apoptosis of breast cancer MCF‐7 cells and is associated with poor prognosis of breast cancer patients

  2019cites this paper
• miR-205 promotes apoptosis of hepatoma cells and enhances cisplatin drug sensitivity by inhibiting ERK1

  2019cites this paper
• Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity

  2019cites this paper
• Exosomal microRNA-205 is involved in proliferation, migration, invasion, and apoptosis of ovarian cancer cells via regulating VEGFA

  2019cites this paper
• Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer.

  2018cites this paper
• Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer

  2018cites this paper
• Transcriptome Signatures of Canine Mammary Gland Tumors and Its Comparison to Human Breast Cancers

  2018cites this paper
• MicroRNAs in regulation of triple-negative breast cancer progression

  2018cites this paper
• Inflammatory breast cancer biology: the tumour microenvironment is key

  2018cites this paper
• Proliferation-associated miRNAs-494, -205, -21 and -126 detected by in situ hybridization: expression and prognostic potential in breast carcinoma patients

  2018cites this paper
• Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.

  2017cites this paper
• The microRNA-205-5p is correlated to metastatic potential of 21T series: A breast cancer progression model

  2017cites this paper
• The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer.

  2017cites this paper
• MicroRNAs: Promising Potential Targets for Cancer Treatment

  2016cites this paper